Aurinia Pharmaceuticals Inc.

Aurinia Pharmaceuticals Inc. is a fully integrated biopharmaceutical company focused on developing and delivering therapies to treat autoimmune diseases with high unmet medical needs. Their mission is to change the trajectory of autoimmune diseases, enabling patients to live their fullest lives. They have a proven track record, having successfully developed LUPKYNIS® (voclosporin), the first FDA-approved oral therapy for the treatment of adult patients with active lupus nephritis (LN). Aurinia is committed to scientific innovation and patient-centric approaches, collaborating with leading healthcare providers and institutions to advance the science and develop transformative new treatment options.

Beyond their core focus on lupus nephritis, Aurinia has a growing pipeline of promising therapies targeting other autoimmune diseases. They are committed to health equity and actively work to improve the lives of people living with autoimmune diseases through education, advocacy, and research. Aurinia has been recognized for their leadership in the healthcare community, receiving awards for their work in developing LUPKYNIS and for their commitment to corporate social responsibility.

Aurinia Pharmaceuticals offers a flexible work environment that prioritizes employee well-being. They provide a comprehensive benefits package that includes paid time off, federal/statutory holidays, and a floating holiday. Aurinia also provides several resources to support employees' learning and development, including LinkedIn Learning, facilitated workshops, and tuition reimbursement. Additionally, they offer an Employee Assistance Program (EAP), health and wellness programs, and on-site gym facilities at no cost. These benefits demonstrate Aurinia's commitment to creating a positive and supportive work environment that values employee flexibility and growth.

Aurinia Pharmaceuticals offers a comprehensive benefits package designed to support the well-being of their employees and families. Benefits include health, dental, and vision insurance, flexible spending accounts, health savings plans, life and accidental death & dismemberment insurance, critical illness insurance, retirement savings plans, an employee stock purchase plan, paid time off, federal/statutory holidays, a floating holiday, LinkedIn Learning, facilitated workshops, an employee assistance program, tuition reimbursement, a health and wellness program, an on-site gym at no cost, and a variety of healthy snack options.

Aurinia Pharmaceuticals Inc. is a biopharmaceutical company dedicated to changing the trajectory of autoimmune diseases. Their mission is to develop and deliver transformative therapies that significantly enhance how patients manage their diseases and enable them to live their fullest lives. Aurinia is driven by the urgency to address unmet medical needs in the autoimmune space, particularly for patients with lupus nephritis, and they strive to achieve this through scientific innovation, clinical excellence, and collaborative partnerships.

Aurinia Pharmaceuticals promotes a culture that prioritizes innovation, integrity, and inclusion. They foster a patient-centric environment that values diverse thinking and collaboration, striving to accelerate scientific breakthroughs. They invest in employee development and offer competitive benefits to foster a rewarding employee experience, with a focus on ensuring equitable access to clinical trials and affordable medicines. This commitment to excellence and social responsibility defines their workplace culture, creating a dynamic environment where individuals can contribute their best and grow their careers.

Aurinia Pharmaceuticals Inc. is committed to creating an inclusive and equitable workplace that accelerates diverse thinking and ideas into scientific breakthroughs. They value every voice and perspective, striving to develop groundbreaking therapies for patients from diverse cultures and geographies. Their commitment is demonstrated through hiring practices, collaborations with external partners, and the recruitment of patients from diverse backgrounds into clinical trials.